7.00am Registration & Morning Coffee

8:05 am Chair’s Opening Remarks

  • Gregory Fiore Member Board of Directors, Exacis Biotherapeutics

Emergence of mRNA-Based Therapeutics & Vaccines 2.0

8:15 am Biopharma Leaders’ Fireside Chat – Evaluating Progress of mRNA Therapies in 2023: Where are we Succeeding & Where are the Gaps?

9:00 am Moderna’s mRNA-1345 Vaccine in Older Adults

  • Sonia Stoszek Executive Director & Program Lead – RSV Vaccines, Moderna

9:30 am BioNTech’s Update on mRNA-Based Vaccines & Other mRNA-Based Therapeutics in Clinical Development

10:00 am Assessing the Industry’s Landscape & Preparing for the Future

  • Aaron Larsen Senior Director & Technical Head - Nucleic Acid Franchise, Resilience Inc

10.30 Morning Break & Speed Networking

1.00 Lunch Break & Networking

3.30 Tech Slam

Synopsis

Capture.PNG

Hosted in Grand Ballroom C

Unraveling the Complex mRNA Landscape: Exploring Opportunities for Future Collaborations

4:15 pm Biopharma Partnerships Panel Exploring the Future of mRNA Investment & Collaborations

  • June Kim CMC Lead, CEPI
  • AJ Bergmann Chief Financial Officer, Capricor
  • Nathaniel Wang Chief Executive Officer & Co-Founder, Replicate Bioscience
  • Pierre Cote Head of Strategic Partnership & Innovation Management, Sanofi
  • John Androsavich Head of Global Ribonucleic Acid & Emerging Science Lead, Pfizer
  • Rachel Groppo Director - Replicon Team Leader, Johnson & Johnson

5:00 pm When Molecules Grow Up: Adaptations & Considerations for Your Manufacturing Strategies

5:30 pm A Look at the Past, Present & Future of mRNA Therapeutics

6:00 pm Chair’s Closing Remarks

  • Rachel Groppo Director - Replicon Team Leader, Johnson & Johnson

6:05 pm End of Day One

6:15 pm Poster Session & Drinks Reception